Milestone Scientific Showcases the CompuFlo(R) Epidural Instrument at ASRA 2019
Connecting Tactile Feel with Intelligence Improves First Attempt Placement for Any Technique LIVINGSTON, NJ / ACCESSWIRE / April 11, 2019...
user
Evotec And Indivumed Announce Strategic Drug Discovery Collaboration On Precision Medicine For Colorectal Cancer
The collaboration leverages Indivumed's true multi-omics cancer database "IndivuType" and Evotec's drug discovery platforms to identify new therapeutics for colorectal...
MorphoSys Nominates New Candidate for Supervisory Board
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 10, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ:...
Jaguar Health, Inc. Reports 2018 Fourth Quarter and Year End Financial Results
Mytesi® Gross Sales and Net Sales Grew 237% and 185%, Respectively, in the Year End 2018 Compared to Year End...
CENTOGENE Launches CentoMetabolic(TM) Panel for Integrated Multiomic Testing for Metabolic Diseases
Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions ROSTOCK and BERLIN, GERMANY /...
EastWest Bioscience Receives TSX Approval for Operations in Kentucky, USA with Eight New CBD Products
VANCOUVER, BC / ACCESSWIRE / April 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands into Kentucky,...
MorphoSys to Present at Upcoming Investor Conferences
MUNICH, GERMANY / ACCESSWIRE / April 9, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ:...
Neuro-ID Introduces Groundbreaking Source of Real-Time Behavioral Intelligence to Predict Customer Outcomes and Enhance the Digital CX
First-Of-Its-Kind Data Provides a New Dimension of Customer Insight Based on Neuroscience and Advanced Behavioral Analytics SAN FRANCISCO, CA /...
Streamline Health to Report Fourth Quarter and Fiscal Year 2018 Financial Performance on April 22, 2019
ATLANTA, GA / ACCESSWIRE / April 9, 2019 / Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of integrated solutions, technology-enabled...
Identifying Grass Pollen That Gets Up Your Nose
First results of a major three-year project to analyze airborne grass pollen LONDON, UK / ACCESSWIRE / April 8, 2019...
Applied BioSciences Retains the Emmes Group to Partner on Therapeutic Development Initiatives
LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company...
Easton Provides Update on the Closing of its Agreement To Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
TORONTO, ON / ACCESSWIRE / April 8, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides update on the closing...
Virpax(R) Pharmaceuticals Announces R&D Collaborative Initiative with Kannaba Technologies
Companies to Combine Cutting-Edge Delivery Technologies, Coupled with Advanced Computational Capabilities and Robotics for Development of Innovative Cannabinoid-Based Biopharmaceuticals MALVERN,...
EFX Laboratories Commences Commercial Capsule Sales Through Strategic Partnership
VANCOUVER, BC / ACCESSWIRE / April 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTC...
Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman to Board of Directors
Mr. Goldman also joins newly formed Board special committee established to evaluate strategic options LIVINGSTON, NJ / ACCESSWIRE / April...
ORYZON to Present First in Human Efficacy Data with Vafidemstat at the 27th European Congress of Psychiatry in Warsaw
Efficacy data from the REIMAGINE Phase IIa basket trial's Borderline Personality Disorder (BPD) cohort Vafidemstat is an active compound in...
Oncolytics Biotech(R) Announces First Patient Treated in Company’s AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer
- Study to generate comprehensive biomarker data by breast cancer sub-type to support phase 3 registration program - Interim data...
EVITRADE Signs LOI with Medical Delivery App and Update on Time-Release Drug Delivery System Joint Venture
VANCOUVER, BC / ACCESSWIRE / April 5, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Year Ended 31 December 2018 and 2019 Guidance
Parnell Delivers 39% Revenue Growth and a $6.5 Million Improvement in EBITDA in 2018 Compared to 2017, Returns to NPAT...
Frank Magliochetti on the Potential of Pharmacogenomic Testing to Reduce Healthcare Costs
LAWRENCE, MA / ACCESSWIRE / April 4, 2019 / Healthcare spending in the United States reached $3.5 trillion in 2017,...